Sarcoma Metabolomics: Current Horizons and Future Perspectives

被引:9
|
作者
Esperanca-Martins, Miguel [1 ,2 ,3 ]
Fernandes, Isabel [1 ,3 ,4 ]
Soares do Brito, Joaquim [4 ,5 ]
Macedo, Daniela [6 ]
Vasques, Hugo [4 ,7 ]
Serafim, Teresa [2 ]
Costa, Luis [1 ,3 ,4 ]
Dias, Sergio [2 ,4 ]
机构
[1] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Med Oncol Dept, P-1649028 Lisbon, Portugal
[2] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Vasc Biol & Canc Microenvironm Lab, P-1649028 Lisbon, Portugal
[3] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Translat Oncobiol Lab, P-1649028 Lisbon, Portugal
[4] Univ Lisbon, Fac Med, P-1649028 Lisbon, Portugal
[5] Ctr Hosp Univ Lisboa Norte, Hosp Santa Maria, Orthoped & Traumatol Dept, P-1649028 Lisbon, Portugal
[6] Hosp Lusiadas Lisboa, Med Oncol Dept, P-1500458 Lisbon, Portugal
[7] Inst Portugues Oncol Francisco Gentil, Gen Surg Dept, P-1099023 Lisbon, Portugal
关键词
sarcoma; soft tissue sarcoma; bone sarcoma; gastrointestinal stromal tumor; metabolomics; metabolism; SOFT-TISSUE SARCOMA; IN-VITRO; CELL-LINES; CANCER; OSTEOSARCOMA; TUMORS; METABOLISM; INHIBITORS; HALLMARKS; PATHWAY;
D O I
10.3390/cells10061432
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The vast array of metabolic adaptations that cancer cells are capable of assuming, not only support their biosynthetic activity, but also fulfill their bioenergetic demands and keep their intracellular reduction-oxidation (redox) balance. Spotlight has recently been placed on the energy metabolism reprogramming strategies employed by cancer cells to proliferate. Knowledge regarding soft tissue and bone sarcomas metabolome is relatively sparse. Further characterization of sarcoma metabolic landscape may pave the way for diagnostic refinement and new therapeutic target identification, with benefit to sarcoma patients. This review covers the state-of-the-art knowledge on cancer metabolomics and explores in detail the most recent evidence on soft tissue and bone sarcoma metabolomics.
引用
收藏
页数:23
相关论文
共 50 条
  • [21] Metabolomics in Team-Sport Athletes: Current Knowledge, Challenges, and Future Perspectives
    Bongiovanni, Tindaro
    Lacome, Mathieu
    Fanos, Vassilios
    Martera, Giulia
    Cione, Erika
    Cannataro, Roberto
    PROTEOMES, 2022, 10 (03)
  • [22] Probiotics: current landscape and future horizons
    Day, Richard L. J.
    Harper, Ashton J.
    Woods, Rachel M.
    Davies, Owen G.
    Heaney, Liam M.
    FUTURE SCIENCE OA, 2019, 5 (04):
  • [23] Synovial sarcoma: current perspectives
    Brennan, Bernadette
    CLINICAL ONCOLOGY IN ADOLESCENTS AND YOUNG ADULTS, 2016, 6 : 21 - 26
  • [24] Obesity: Current Treatment and Future Horizons
    Omran, Ziad
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2017, 17 (01) : 51 - 61
  • [25] Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management
    Thomas, David M.
    O'Sullivan, Brian
    Gronchi, Alessandro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (08) : 1145 - 1157
  • [26] Metabolomics for exposure assessment and toxicity effects of occupational pollutants: current status and future perspectives
    Dehghani, Fatemeh
    Yousefinejad, Saeed
    Walker, Douglas, I
    Omidi, Fariborz
    METABOLOMICS, 2022, 18 (09)
  • [27] Understanding PFAS toxicity through cell culture metabolomics: Current applications and future perspectives
    Nguyen, Thao, V
    Trang, Phan Nguyen
    Kumar, Anu
    ENVIRONMENT INTERNATIONAL, 2024, 186
  • [28] Metabolomics for exposure assessment and toxicity effects of occupational pollutants: current status and future perspectives
    Fatemeh Dehghani
    Saeed Yousefinejad
    Douglas I. Walker
    Fariborz Omidi
    Metabolomics, 18
  • [29] PARKINSONISM - CURRENT PERSPECTIVES AND NEW HORIZONS - INTRODUCTION
    YAHR, MD
    CLINICAL NEUROPHARMACOLOGY, 1986, 9 : S1 - S1
  • [30] METABOLOMICS: CURRENT TECHNOLOGIES AND FUTURE TRENDS
    Pawar, A. Krishnamanjari
    Samhitha, T.
    Prasanna, B.
    Asif, M. Lavanya
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (06): : 5114 - 5121